五月 2026
- Home
- ExecuPharm
五月 2026的ExecuPharm市场份额分析
for over 35 years parexel has been a trusted global cro and biopharmaceutical services company. learn more about how we can help.
ExecuPharm(包含公司地区分支机构)
查看更多网站流量和参与度信息- execupharm.com
ExecuPharm收入截至 五月 2026为 200M - 500M
ExecuPharm主要域名产生的收入
3 年中ExecuPharm主要域名的收入
ExecuPharm主要域名的收入
ExecuPharm热门域名的总访问量
了解ExecuPharm市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
无数据可显示
无数据可显示
ExecuPharm热门域名的平均访问时长
分析ExecuPharm参与度指标。
过去 3 个月的平均访问时长
无数据可显示
无数据可显示
ExecuPharm热门域名的平均页面浏览量
了解ExecuPharm如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
无数据可显示
无数据可显示
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
ExecuPharm 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻Parexel acquired Execupharm for $1.2B on Sep 1st '16.This ecosystem is characterized by strategic mergers, acquisitions, and technology adoption, as seen in Lonza's acquisition of a Genentech manufacturing facility, valued at $1.2 billion, and Parexel's acquisition of ExecuPharm to enhance and strengthen its capacity in clinical studies.
九月 4, 2025阅读更多
新闻Execupharm has issues with stolen by threat actors in a 2020 ransomware attack.The plaintiff in Clemens was a former ExecuPharm employee whose sensitive personal data, including her social security number, was stolen by threat actors in a 2020 ransomware attack against ExecuPharm.
十月 19, 2022阅读更多
新闻Execupharm has issues with data breach.The appeals court reversed a Pennsylvania district court's dismissal of claims brought by a former ExecuPharm employee seeking equitable and monetary relief over a data breach that resulted in the publication of her personal information on the Dark Web.
九月 7, 2022阅读更多
查看 ExecuPharm 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。
